Table 1 Detectable differences for dichotomous outcome measures
Outcome | Tapering/discontinuation | Maintenance treatment | Reference |
|---|---|---|---|
Remission and no antipsychotics (primary outcome) | 39.7% | 23.3% | Godtfredsen [21] |
Stable remission of psychotic symptoms and max 1-mg haloperidol equivalents (most important secondary outcome measure) | 15.4% | 4.8% | Wunderink [22] |
Percentage in recovery after 7 years (exploratory outcome measure) | 33.4% | 17.6% | Wunderink [23] |